Literature DB >> 7498659

Virion-like structures in HeLa G cells transfected with the full-length sequence of the hepatitis C virus genome.

M Mizuno1, G Yamada, T Tanaka, K Shimotohno, M Takatani, T Tsuji.   

Abstract

BACKGROUND & AIMS: The process and the site of hepatitis C virus (HCV) particle formation in cells after infection remain unknown. The aim of this study was to create an in vitro model for the study of HCV particle formation.
METHODS: HeLa G cells were transfected with the full-length sequence of the HCV genome. Viral protein expression was analyzed using immunoblotting. The cells were examined using immunoelectron and conventional electron microscopy.
RESULTS: Core, E2, NS3, NS5a, and NS5b proteins were identified using immunoblotting. Immunoelectron microscopy showed that the core antigen was located along the membrane of the endoplasmic reticulum (ER) and occasionally in its cisternae. Core antigen-positive particles of 30 nm in diameter were found in the cytosol and in the cisternae of the ER. The particles in the cisternae were coated with an outer membrane that was connected to the ER membrane. Conventional electron microscopy revealed particles of 45 nm in diameter with electron-dense cores in the cisternae of the ER. The outer membrane of the particles was occasionally connected to the ER membrane.
CONCLUSIONS: The findings suggest that HCV core proteins are synthesized and assembled into particles in the cytosol and that they bud into the cisternae of the ER to form coated particles.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7498659     DOI: 10.1016/0016-5085(95)90761-0

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  16 in total

1.  Transfection of HepG2 cells with infectious hepatitis C virus genome.

Authors:  S Dash; A B Halim; H Tsuji; N Hiramatsu; M A Gerber
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

2.  Hepatitis C virus replication and potential targets for direct-acting agents.

Authors:  Jacqueline G O'Leary; Gary L Davis
Journal:  Therap Adv Gastroenterol       Date:  2010-01       Impact factor: 4.409

3.  Inhibition effect of Chinese herbal medicine on transcription of hepatitis C virus structural gene in vitro.

Authors:  Jun Dou; Qian Chen; Jing Wang
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

4.  Hepatitis C virus structural proteins assemble into viruslike particles in insect cells.

Authors:  T F Baumert; S Ito; D T Wong; T J Liang
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

Review 5.  Histopathology and detection of hepatitis C virus in liver.

Authors:  P J Scheuer; K Krawczynski; A P Dhillon
Journal:  Springer Semin Immunopathol       Date:  1997

6.  Self-assembly of nucleocapsid-like particles from recombinant hepatitis C virus core protein.

Authors:  M Kunkel; M Lorinczi; R Rijnbrand; S M Lemon; S J Watowich
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

7.  Ultrastructural and biophysical characterization of hepatitis C virus particles produced in cell culture.

Authors:  Pablo Gastaminza; Kelly A Dryden; Bryan Boyd; Malcolm R Wood; Mansun Law; Mark Yeager; Francis V Chisari
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

8.  Efficient class II major histocompatibility complex presentation of endogenously synthesized hepatitis C virus core protein by Epstein-Barr virus-transformed B-lymphoblastoid cell lines to CD4(+) T cells.

Authors:  M Chen; M Shirai; Z Liu; T Arichi; H Takahashi; M Nishioka
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

9.  Cloning and expression of core gene cDNA of Chinese hepatitis C virus in cosmid pTM3.

Authors:  Rong-Long Jiang; Qiao-Sheng Lu; Kang-Xian Luo
Journal:  World J Gastroenterol       Date:  2000-04       Impact factor: 5.742

10.  Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion.

Authors:  Pablo Gastaminza; Guofeng Cheng; Stefan Wieland; Jin Zhong; Wei Liao; Francis V Chisari
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.